Cultivated mammalian cells, known as “mammalian fermentation,” have become the dominant system for the production of recombinant proteins for clinical applications.
To bring these complex products to market involves significant effort and continuous advances in process development. These efforts aim to increase the level of product understanding and identify those key quality attributes that help in reproducing product batches.
To address the current state of science and practice in this field, UC San Diego Extension will co-present a three-day course titled “Mammalian Fermentation Workshop,” April 30 through May 2, at the UC San Diego campus.
Developed in partnership with UC San Diego’s Center for Continuing Education in Biosciences, part of the Biological Sciences Division, the program features both UC San Diego faculty members and industry-based speakers.
The course also includes a site visit to Genentech, the San Diego-based biotech firm that has made significant advances in developing protein therapeutics to treat patients with serious or life-threatening medical conditions.
"Today’s sophisticated pharmaceutical drugs are not just chemicals, but also biological agents, such as proteins and antibodies,” said Hugo Villar, director of science and technology at UC San Diego Extension. “Their production requires the use of cell culture and fermentation techniques that have become extremely important in the biotechnology and pharmaceutical industries, and it requires the optimization of a number of complex variables.”
Open to the public, the two-unit workshop is designed for professionals with a broad range of industry skills and experiences who wish to expand on their current knowledge and improve their ability to problem-solve. Having a rudimentary understanding of microbial or mammalian cell culture processes is advised.
For more information and to register for this workshop, please visit us online at extension.ucsd.edu or call (858) 534-3400.